HCM patients (n = 143) | Control subjects (n = 15) | |||||
---|---|---|---|---|---|---|
Trabeculations and papillary muscles included in the blood pool (incl) | Trabeculations and papillary muscles excluded from the blood pool (excl) | p | Trabeculations and papillary muscles included in the blood pool (incl) | Trabeculations and papillary muscles excluded from the blood pool (excl) | p | |
LVEDV (ml) | 182.0 (157.0–204.0) | 122.0 (103.0–137.0) | < 0.0001 | 198.0 (160.2–210.5) | 147.0 (118.2–164.0) | 0.0001 |
LVESV (ml) | 64.0 (52.0–79.0) | 27.0 (21.0–34.7) | < 0.0001 | 62.0 (53.7–82.2) | 37.0 (27.5–49.7) | 0.0001 |
LVSV (ml) | 115.0 (97.3–129.0) | 90.0 (78.0–105.0) | < 0.0001 | 119.0 (104.7–137.5) | 103.0 (86.0–109.2) | 0.0001 |
LVEF (%) | 63.7 (60.1–67.5) | 77.0 (72.0–82.0) | < 0.0001 | 64.0 (61.3–69.1) | 73.0 (68.3–76.5) | 0.0001 |
LVM (g) | 152.0 (119.2–198.0) | 214.0 (170.8–274.7) | < 0.0001 | 123.0 (95.5–141.2) | 168.0 (138.0–199.2) | 0.0001 |